Clinical Trials Concentrates Microdosing Treatment 
Cannabis Law Report
FEBRUARY 14, 2020
a Canadian biotech firm, is entering Phase II clinical trials for two experimental treatments. According to its website, one trial involves an ibogaine-derived drug for treating opioid addiction. The other trial will test LSD microdosing as an ADHD treatment. Mind Medicine, Inc. ,
The Cannigma
DECEMBER 12, 2022
Scientists are hopeful that psychedelics might have more of a curative effect when it comes to mental health than many existing treatment options; meaning that unlike most psychiatric medications, psychedelics may be able to prompt long-term changes to our mental state with only a few doses. What is microdosing? Are psychedelics safe?
The Cannigma
JUNE 24, 2021
These natural alternatives may also be effective as part of a daily “microdosing” regiment. While more human clinical trials are needed, the current evidence suggests there may be potential therapeutic benefits for the following ailments: Chronic pain — the most common reason people turn to medical cannabis in the United States today.
Expert insights. Personalized for you.
45 
Let's personalize your content